Bio-Rad (BIO.B) Reports Q4 Profit of $720M, EPS $26.65; Revenue $693.2M

Bio-Rad Laboratories Inc. (BIO.B) reported fourth-quarter net income of $720 million, a reversal from a loss in the same period last year. Adjusted earnings per share were $2.51, with revenue of $693.2 million. For the year, the company recorded net income of $759.9 million, or $27.85 per share, and revenue of $2.58 billion. Bio-Rad shares fell 5% year-to-date and closed at $295.05 on Thursday, reflecting a 14% decline over the past 12 months.